Adamax is a name used for a research compound marketed as a modified Semax-related peptide. It is promoted by vendors for research into cognitive and neurological pathways. However, its precise chemical identity, published research, and pharmacological properties have not been sufficiently established. Its composition should be verified through manufacturer documentation.